is humalog a glp-1 New Guidelines for Type 2 Diabetes in 2025 Prescription GLP-1s for Weight Loss

Looking ahead, with breakthroughs in novel molecular designs, oral formulations, small molecule drugs, and dual-target drugs pushing the boundaries of GLP-1 drug innovation, the market is expected to continue to grow.

As a member of the Apex Skin team and a patient in the practices Total Body program, Amber has a front-row seat to what a complete transformation actually looks like

Week 1: 10 mg = 1.0 mL (100 units)

Market uncertainty makes it more critical than ever to understand how your consumer base is thinking and feeling about the GLP-1 landscape

The GLP-1 drug development programme requires answers to dozens of questions simultaneously

The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning insulin is only released when blood glucose levels are elevated Suppressing glucagon release from pancreatic alpha cells, which reduces hepatic glucose production Slowing gastric emptying , which helps moderate post-meal blood glucose spikes Reducing appetite through central nervous system effects, leading to decreased caloric intake and weight loss Examples of GLP-1 receptor agonists available in the UK include exenatide (Byetta, Bydureon), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity), lixisenatide (Lyxumia), and semaglutide (Ozempic/Rybelsus for diabetes, Wegovy for weight management)